CHARACTERISTICS OF THE GRACE SCORE IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION AND DIABETES

Nguyễn Phương Hải Trần, Thanh Tú Nguyễn

Main Article Content

Abstract

Introduction: Acute myocardial infarction is a common disease, causing high morbidity and mortality. No studies in Vietnam have used this scale to predict patients with acute myocardial infarction and type 2 diabetes. Objectives: Describe the characteristics of the GRACE score in patients with acute myocardial infarction and diabetes. Subjects - Methods: Prospectively describe a group of patients with acute myocardial infarction and type 2 diabetes. Stratify into low, medium, and high-risk categories of in-hospital mortality when GRACE score is ≤ 108, 109-140, and > 140. Results: From November 2022 to June 2023, 232 patients were surveyed. Among them, 49.14% were men, with an average age of 66.17 ± 10.05 years. Cardiovascular risk factors included dyslipidemia, hypertension, smoking, and a family history of premature cardiovascular disease, accounting for 90.52%, 89.66%, 30.17%, and 2.16%, respectively. The average GRACE score was 122.53 ± 28.25, with the lowest being 60 and the highest being 222. Risk stratification according to GRACE score showed low, medium, and high-risk categories accounting for 31.47%, 47.41%, and 21.12%, respectively. The average GRACE score in the ST-elevation myocardial infarction group was significantly higher than in the non-ST-segment elevation myocardial infarction group, 129.31 ± 29.64 and 117.12 ± 25.95, respectively, with p=0.002. Conclusion: Patients with acute myocardial infarction and type 2 diabetes have relatively high GRACE scores. The average GRACE score of the ST-segment elevation myocardial infarction group was higher than that of the non-ST-segment elevation myocardial infarction group.

Article Details

References

1. Yeh RW, et al. Population trends in the incidence and outcomes of acute myocardial infarction. N Engl J Med. Jun 10 2010; 362(23): 2155-65. doi:10.1056/NEJMoa0908610
2. Babes EE, et al. Acute coronary syndromes in diabetic patients, outcome, revascularization, and antithrombotic therapy. Biomed Pharmacother. Apr 2022; 148: 112772. doi: 10.1016/j.biopha .2022.112772
3. Collet JP, et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. Apr 7 2021;42(14):1289-1367. doi:10.1093/eurheartj/ehaa575
4. Linh NK. Đánh giá khả năng dự báo biến cố của thang điểm TIMI và GRACE trên bệnh nhân hội chứng mạch vành cấp. Trường đại học Y Dược, Đại học Quốc gia Hà Nội. 2021.
5. Kao YT, et al. Comparison of the TIMI, GRACE, PAMI and CADILLAC risk scores for prediction of long-term cardiovascular outcomes in Taiwanese diabetic patients with ST-segment elevation myocardial infarction: From the registry of the Taiwan Society of Cardiology. PLoS One. 2020;15(2): e0229186. doi: 10.1371/journal. pone.0229186
6. Baeza-Román A, et al. Predictive power of the grace score in population with diabetes. Int J Cardiol. Dec 1 2017;248:73-76. doi:10.1016/ j.ijcard.2017.06.083
7. Baluja A, et al. Prediction of major adverse cardiac, cerebrovascular events in patients with diabetes after acute coronary syndrome. Diab Vasc Dis Res. Jan-Feb 2020; 17(1): 1479164119892137. doi: 10.1177/ 1479164119892137
8. Neves VB, et al. Validation of the Grace Risk Score to Predict In-Hospital and 6-Month Post-Discharge Mortality in Patients with Acute Coronary Syndrome. International Journal of Cardiovascular Sciences. 2021;35(2):174-180. doi:10.36660/ijcs.20210019